Page last updated: 2024-08-24

imiquimod and plx4032

imiquimod has been researched along with plx4032 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cohen, DN; Johnson, DB; Joseph, RW; Kelley, MC; Likhari, SS; Powers, JG; Shinn, L; Sosman, JA; Wallender, EK; Zwerner, JP	1
Chang, SE; Lee, MW; Lee, YJ; Rhee, do Y; Won, CH; Won, KH	1

Other Studies

2 other study(ies) available for imiquimod and plx4032

Article	Year
Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy. Cancer immunology research, 2013, Volume: 1, Issue:6 Topics: Adult; Aminoquinolines; Anaphylaxis; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Female; Guillain-Barre Syndrome; Humans; Imiquimod; Indoles; Melanoma; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Skin Neoplasms; Sulfonamides; Vemurafenib	2013
Successful treatment of multiple vemurafenib-induced keratoacanthomas by topical application of imiquimod cream: Confirmation of clinical clearance by dermoscopy. The Journal of dermatological treatment, 2016, Volume: 27, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Eruptions; Female; Humans; Imiquimod; Indoles; Keratoacanthoma; Melanoma; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib	2016

Article

Year

Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy.

Cancer immunology research, 2013, Volume: 1, Issue:6

Topics: Adult; Aminoquinolines; Anaphylaxis; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Female; Guillain-Barre Syndrome; Humans; Imiquimod; Indoles; Melanoma; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Skin Neoplasms; Sulfonamides; Vemurafenib

2013

Successful treatment of multiple vemurafenib-induced keratoacanthomas by topical application of imiquimod cream: Confirmation of clinical clearance by dermoscopy.

The Journal of dermatological treatment, 2016, Volume: 27, Issue:5

Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Eruptions; Female; Humans; Imiquimod; Indoles; Keratoacanthoma; Melanoma; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib

2016